摘要
目的观察黄芪预防低钾型周期性麻痹(HoPP)的临床效果及安全性。方法将61例HoPP患者随机分为治疗组31例和对照组30例,治疗组予黄芪颗粒治疗,对照组不予药物治疗。结果①治疗组在第3月时的复发率为16.1%,显著低于对照组的40.0%(P<0.05)。②治疗组在复发时的血清钾为2.36±0.18mmol/L,显著高于对照组的2.05±0.22mmol/L(P<0.01)。③两组在复发时的四肢肌力和心电图改变的比较,差异无显著性(P>0.05)。结论黄芪有较好的预防HoPP的作用,且无不良反应。
Objective To investigate the effects and safety of HuangQi in preventing patients from hypokalemic periodic paralysis （HoPP）. Methods 61 HoPP cases were divided randomly into treatment group and control group, receiving HuangQi Keli and no drug respectively . Results （1）The re-occurrence rate of treatment group after three months was 16.1%,which was significantly lower than 40.0% of control group . （2）The blood potassium of treatment group at re-occurrence was 2.36±0.18mmol/ L, which was significantly higher than 2.05±0.22mmol/L of control group. （3）There was no significant difference between two groups in myodynamia and electrocardiogram alteration at re-occurrence. Conclusion HuangQi is effective in preventing patients from HoPP, and it has no serious side effects.
出处
《中国现代医药杂志》
2006年第2期11-12,共2页
Modern Medicine Journal of China
关键词
黄芪
低钾
周期性麻痹
预防
HuangQi hypokalemia Periodic paralysis
